Search

Your search keyword '"Bordoni, Veronica"' showing total 290 results

Search Constraints

Start Over You searched for: Author "Bordoni, Veronica" Remove constraint Author: "Bordoni, Veronica"
290 results on '"Bordoni, Veronica"'

Search Results

1. Tumor-derived G-CSF induces an immunosuppressive microenvironment in an osteosarcoma model, reducing response to CAR.GD2 T-cells

2. Innate and SARS-CoV-2 specific adaptive immune response kinetic in neutralizing monoclonal antibody successfully treated COVID-19 patients

4. Humoral and cellular immune response after mRNA SARS-CoV-2 vaccine in children on treatment for cancer: A pilot observational study

5. SARS-CoV-2 infection of thymus induces loss of function that correlates with disease severity

6. Identification of an immunological signature of long COVID syndrome.

8. Safety and immune response kinetics of GRAd-COV2 vaccine: phase 1 clinical trial results

9. Immunogenicity to COVID-19 mRNA vaccine third dose in people living with HIV

10. Persistent Spike-specific T cell immunity despite antibody reduction after 3 months from SARS-CoV-2 BNT162b2-mRNA vaccine

13. Risk and predictive factors of prolonged viral RNA shedding in upper respiratory specimens in a large cohort of COVID-19 patients admitted to an Italian reference hospital

15. 2019-novel Coronavirus severe adult respiratory distress syndrome in two cases in Italy: An uncommon radiological presentation

17. Expansion of myeloid-derived suppressor cells in patients with severe coronavirus disease (COVID-19)

18. Multi-omics approach to COVID-19: a domain-based literature review

19. Long Term Assessment of Anti-SARS-CoV-2 Immunogenicity after mRNA Vaccine in Persons Living with HIV

20. Long Term Assessment of Anti-SARS-CoV-2 Immunogenicity after mRNA Vaccine in PLWH

22. Early expansion of myeloid-derived suppressor cells inhibits SARS-CoV-2 specific T-cell response and may predict fatal COVID-19 outcome

23. P1461: INFLAMMATORY AND SENESCENCE-ASSOCIATED MEDIATORS AFFECT THE PERSISTENCE OF HUMORAL RESPONSE TO COVID-19 MRNA VACCINATION IN TRANSFUSION-DEPENDENT BETA-THALASSEMIC PATIENTS

26. Functional CVIDs phenotype clusters identified by the integration of immune parameters after BNT162b2 boosters

27. Inflammatory and senescence‐associated mediators affect the persistence of humoral response to COVID ‐19 mRNA vaccination in transfusion‐dependent beta‐thalassemic patients

29. The BNT162b2 vaccine induces humoral and cellular immune memory to SARS-CoV-2 Wuhan strain and the Omicron variant in children 5 to 11 years of age

32. Humoral and T-cell immune response after three doses of mRNA SARS-CoV-2 vaccines in fragile patients: the Italian VAX4FRAIL study

36. Functional CVIDs phenotype clusters identified by the integration of immune parameters after BNT162b2 boosters.

38. Myeloid-Derived Suppressor Cells in COVID-19: The Paradox of Good

40. Humoral and T-cell immune response after three doses of mRNA SARS-CoV-2 vaccines in fragile patients: the Italian VAX4FRAIL study

41. The BTN162b2 Vaccine Induces Humoral and Cellular Immune Memory to Wuhan Strain SARS-CoV-2 and the Omicron Variant in Children 5 to 11 Years of Age

44. Humoral and T-Cell Immune Response After 3 Doses of Messenger RNA Severe Acute Respiratory Syndrome Coronavirus 2 Vaccines in Fragile Patients: The Italian VAX4FRAIL Study.

45. Pleural Mesothelial Cells Modulate the Inflammatory/Profibrotic Response During SARS-CoV-2 Infection

46. Predicting respiratory failure in patients infected by SARS-CoV-2 by admission sex-specific biomarkers

47. Additional file 1 of Multi-omics approach to COVID-19: a domain-based literature review

48. Expansion of Myeloid Derived Suppressor Cells Contributes to Platelet Activation by L-Arginine Deprivation during SARS-CoV-2 Infection

49. Pharmacokinetics of remdesivir and GS-441524 in two critically ill patients who recovered from COVID-19

50. An inflammatory profile correlates with decreased frequency of cytotoxic cells in COVID-19

Catalog

Books, media, physical & digital resources